Skip to content
OpenCapital
Get started

Allarity Therapeutics, Inc. ALLR Q3 2025 earnings

Reported November 14, 2025 · Before market open

EPS-$0.19Beat by $0.04
EPS estimate-$0.23

Next report

Aug 21, 2026 (In 3 weeks)
Revenue estimate$25.0K
EPS estimate-$0.25

Versus estimates

Revenue

Q1 2026$25.0KIn lineQ4 2025$320.0KIn lineQ4 2024$6.0K

Diluted EPS

Q1 2026-$0.17Beat by $0.05Q4 2025-$0.19Beat by $0.03
Q3 2025-$0.19Beat by $0.04
Q2 2025-$0.15Beat by $0.06Q1 2025-$0.25Q4 2024-$4.73Beat by $3.37

Ask the moment Allarity Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Allarity Therapeutics, Inc. report Q3 2025 earnings?
Allarity Therapeutics, Inc. (ALLR) reported Q3 2025 earnings on November 14, 2025 before market open.
What were Allarity Therapeutics, Inc.'s Q3 2025 revenue and EPS?
Allarity Therapeutics, Inc. reported eps of $-0.19 for Q3 2025.
Did Allarity Therapeutics, Inc. beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.23 by $0.04.
How did Allarity Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 97.5% from $-7.71.
Where can I find Allarity Therapeutics, Inc.'s Q3 2025 SEC filings?
You can read the 10-Q periodic report (0001437749-25-035003) directly on SEC EDGAR. The filing index links above go to sec.gov.